Refractory Neuroblastoma Recruiting Phase 1 Trials for Dinutuximab (DB09077)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0047201 (Refractory Neuroblastoma) | Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05400603 | Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma | Treatment |